DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Leirisalo-Repo M, Kautiainen H, Laasonen L, Möttönen T. et al.
A randomized, double-blind, placebo-controlled study on addition of infliximab to the FIN-RACO DMARD combination therapy for initial six months in patients with early active rheumatoid arthritis. The NEO-RACO study.
Ann Rheum Dis 2008; 67 ((Suppl II)) 50-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.